Concepedia

Author

Archie Tse

Memorial Sloan Kettering Cancer Center

Also Known As

A Tse, A. N. Tse, A. Tse, A.N. Tse, Archie N. Tse, Archie Tse

124

Publications

4.3K

Citations

25

H-Index

43

Concepts

All Affiliations

Memorial Sloan Kettering Cancer CenterUniversity of Southern CaliforniaAstraZeneca (United Kingdom)Merck & Co., Inc., Rahway, NJ, USA (United States)Virginia Commonwealth University Medical Center
AT

About

Archie Tse is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, radiation oncology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

14

1.2K

2

Health Sciences

4

4

237

3

Engineering

1

1

58

4

Natural Sciences

1

1

21

5

Biochemistry

1

1

21

Archie Tse

×

30

Publications

3.7K

Citations

23

H-Index

YearCitations

Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry

Ki Y. Chung, Jinru Shia, Nancy E. Kemeny,

Journal of Clinical Oncology

2005

1.1K

Multicenter Phase II Study of Irinotecan, Cisplatin, and Bevacizumab in Patients With Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Manish A. Shah, Ramesh K. Ramanathan, David H. Ilson,

Journal of Clinical Oncology

2006

409

AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies

Sonya Zabludoff, Chun Deng, Michael Grondine,

Molecular Cancer Therapeutics

2008

407

Preliminary results of the first-in-human (FIH) study of MK-1454, an agonist of stimulator of interferon genes (STING), as monotherapy or in combination with pembrolizumab (pembro) in patients with advanced solid tumors or lymphomas

Kevin J. Harrington, Joshua Brody, M. Ingham,

Annals of Oncology

2018

258

Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT)

Aurélien Marabelle, Robert Hans Ingemar Andtbacka, Kevin J. Harrington,

Annals of Oncology

2018

204

Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival

William R. Jarnagin, Lawrence H. Schwartz, David H. Gültekin,

Annals of Oncology

2009

184

CHIR-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons <i>In vitro</i> and <i>In vivo</i>

Archie Tse, Katherine G. Rendahl, Tahir Sheikh,

Clinical Cancer Research

2007

149

Aurora B Kinase Regulates the Postmitotic Endoreduplication Checkpoint via Phosphorylation of the Retinoblastoma Protein at Serine 780

Jayasree S. Nair, Alan L. Ho, Archie Tse,

Molecular Biology of the Cell

2009

103

Structural features of 5,10-dideaza-5,6,7,8-tetrahydrofolate that determine inhibition of mammalian glycinamide ribonucleotide formyltransferase

Samuel Baldwin, Archie Tse, Lynn S. Gossett,

Biochemistry

1991

101

Chk1 inhibition after replicative stress activates a double strand break response mediated by ATM and DNA-dependent protein kinase

Samuel McNeely, Chiara Conti, Tahir Sheikh,

Cell Cycle

2010

98

Page 1